BUNZL PLC
No enriched coverage for $BZLFY in the last 7 days.
No SEC Form 4 filings for $BZLFY in the last 30 days.
See all $BZLFY insider activity →Bunzl (BNZL) reported Q3 underlying revenue growth of 3.7%, driven by price increases and volume. North America contributed 53% of revenue. The company maintained its full-year forecast and is executing a £500m share buyback, with £225m completed so far.
Bunzl stock fell 2.3% to 2,746p after its Q3 2026 trading statement met expectations but did not upgrade guidance. Revenue grew 3.1% at constant rates, with underlying revenue up 3.7%. The company reiterated its full-year outlook, expecting modest revenue growth and flat operating margins. Activist investor Elliott, holding 5% of the company, is pushing for a buyback and strategic review. The broader FTSE 100 also declined 0.5%.
Bunzl plc reported a 3.1% increase in quarterly revenue at constant FX, with operating margin expected to remain flat year-on-year. The company acquired Blueleaf Care, a UK distributor serving care homes and the health sector, for an undisclosed amount.
Recent BZLFY coverage spans earnings, mergers & acquisitions and financial news.
Bunzl (BNZL) reported Q3 underlying revenue growth of 3.7%, driven by price increases and volume. North America contributed 53% of revenue. The company maintained its full-year forecast and is executing a £500m share buyback, with £225m completed so far.
Bunzl stock fell 2.3% to 2,746p after its Q3 2026 trading statement met expectations but did not upgrade guidance. Revenue grew 3.1% at constant rates, with underlying revenue up 3.7%. The company reiterated its full-year outlook, expecting modest revenue growth and flat operating margins. Activist investor Elliott, holding 5% of the company, is pushing for a buyback and strategic review. The broader FTSE 100 also declined 0.5%.
Bunzl plc reported a 3.1% increase in quarterly revenue at constant FX, with operating margin expected to remain flat year-on-year. The company acquired Blueleaf Care, a UK distributor serving care homes and the health sector, for an undisclosed amount.
Earnings beat and sizable buyback suggest near‑term upside.
Exclusive CleanWatch™ platform launched ahead of Ontario's Bill 190 July 1, 2025 Deadline.
AlphAI scores every news story that mentions BZLFY with an AI model for sentiment and relevance, and aggregates insider trades from BUNZL PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Bunzl (BNZL) reported Q3 underlying revenue growth of 3.7%, driven by price increases and volume. North America contributed 53% of revenue. The company maintained its full-year forecast and is executing a £500m share buyback, with £225m completed so far.
1 min readBunzl stock fell 2.3% to 2,746p after its Q3 2026 trading statement met expectations but did not upgrade guidance. Revenue grew 3.1% at constant rates, with underlying revenue up 3.7%. The company reiterated its full-year outlook, expecting modest revenue growth and flat operating margins. Activist investor Elliott, holding 5% of the company, is pushing for a buyback and strategic review. The broader FTSE 100 also declined 0.5%.
2 min readBunzl plc reported a 3.1% increase in quarterly revenue at constant FX, with operating margin expected to remain flat year-on-year. The company acquired Blueleaf Care, a UK distributor serving care homes and the health sector, for an undisclosed amount.
1 min readBunzl PLC reported higher earnings for H1 2026, with pre-tax income rising to GBP 290.4 million. Revenue increased to GBP 5.933 billion, driven by volume growth and inflation. The company plans to repurchase up to GBP 500 million of shares over the next year, starting with a GBP 250 million tranche.
2 min readExclusive CleanWatch™ platform launched ahead of Ontario's Bill 190 July 1, 2025 Deadline.
2 min read
